| Operating Room Team Familiarity and Perioperative Outcomes in Non-Cardiac Surgery (NCT07065812) | Zhongda Hospital | 2026-07-15 |
| Early Electroacupuncture for Post-TURP LUTS (NCT07736807) | Zhongda Hospital | 2026-07-01 |
| The Impact of Blood Pressure Variability During the Induction and Surgical Periods on Postoperative Acute Kidney Injury (NCT07602465) | Zhongda Hospital | 2026-06-01 |
| Safety and Efficacy of Docetaxel, Darolutamide, and Homoharringtonine Combined With Androgen Deprivation Therapy in Neoadjuvant Treatment of High-Risk Prostate Cancer: A Multicenter Prospective, Single-Arm Clinical Study (NCT07516704) | Zhongda Hospital | 2026-04-01 |
| Trunk Inclination, Positive End-expiratory Pressure, and Lung Recruitability (NCT07504731) | Zhongda Hospital | 2026-03-20 |
| Assessment of cfDNA-STING Axis as a Potential Pathological Marker in Atopic Dermatitis (NCT07573735) | Zhongda Hospital | 2026-02-01 |
| A Multicenter Prospective Study on the Performance of Spectral CT for Evaluating Treatment Response After TACE in Hepatocellular Carcinoma (NCT07351669) | Zhongda Hospital | 2026-01-20 |
| Propranolol Combined With Novel Endocrine Therapy and Androgen Deprivation Therapy (ADT) for Neoadjuvant Treatment in High-Risk Prostate Cancer Patients: A Multicenter, Single-Arm Clinical Study (NCT07311915) | Zhongda Hospital | 2026-01-15 |
| Effect of Branched-Chain Amino Acid Supplementation on Myopia Progression (NCT07585877) | Zhongda Hospital | 2026-01-05 |
| A Study on the Safety and Effectiveness of Endoscopic Intracavitary Submucosal Dissection for Gastric Extracavitary-Type Submucosal Tumors (NCT07337980) | Zhongda Hospital | 2026-01-01 |
| Effect of Roxadustat on Heart Failure Patients With Anaemia and Moderate-to-Severe Chronic Kidney Disease (NCT07268807) | Zhongda Hospital | 2025-12-01 |
| Sigh Ventilation in Cardiac Surgery (NCT07024420) | Zhongda Hospital | 2025-10-09 |
| EDN Combined With TACE/HAIC and Second-Line Immune-Targeted Treatment Versus TACE/HAIC Alone in Locally Advanced HCC With Portal Vein Tumor Thrombosis After First-Line Therapy Failure: A Prospective, Multicenter, Randomized Controlled Trial (NCT07187284) | Zhongda Hospital | 2025-09-30 |
| A Multicentre Clinical Study (NCT07062666) | Zhongda Hospital | 2025-07-30 |
| Efficacy Analysis of Saccharomyces Boulardii Combined With Minocycline in Treatment-naïve Patients With Helicobacter Pylori Infection (NCT07012785) | Zhongda Hospital | 2025-06-01 |
| SIRT Versus cTACE for Unresectable HCC (CHANCE2506) (NCT06909708) | Zhongda Hospital | 2025-04-03 |
| Dynamic Prediction Model for Patients with Unresectable Biliary Malignancies Receiving Systemic Chemotherapy Combined with Immunotherapy: a Multicenter, Observational Study (NCT06849193) | Zhongda Hospital | 2025-01-31 |
| TACE With Thermosensitive Nanogel Versus Embosphere for HCC (NCT06593964) | Zhongda Hospital | 2024-09-10 |
| Sedation in ICU Patients With Mechanical Ventilation (NCT06538883) | Zhongda Hospital | 2024-08-01 |
| PyroEVs/PLIN3 Mediate Lipid Droplet-Mitochondrial Coupling in Sepsis Endothelial Injury (NCT07727265) | Zhongda Hospital | 2024-07-01 |
| Personalized Ventilation Based on Ventilation-perfusion Mismatch and Lung Recruitability (NCT06430554) | Zhongda Hospital | 2024-06-08 |
| Prognosis Stratification for Advanced HCC Receiving TACE with PD-1/PD-L1 Inhibitors and Molecular Target Therapies (NCT06607120) | Zhongda Hospital | 2024-06-01 |
| Efficacy and Safety of 90Y Microsphere Combined With FOLFIRI and Bevacizumab in Second-line Treatment of CRLM (NCT06447727) | Zhongda Hospital | 2024-05-20 |
| Sigh Ventilation on Postoperative Hypoxemia in Cardiac Surgery (NCT06248320) | Zhongda Hospital | 2024-02-25 |
| TACE Combined With ICIs Plus MTT After 125I Irradiation Stent Placement in HCC With Main PVTT. (NCT06669377) | Zhongda Hospital | 2024-01-01 |
| A Generative Model-based System for Predicting Survival and Guiding Treatment Decisions in Patients With Unresectable Hepatocellularcarcinoma Undergoing Transcatheter Arterial Chemoembolization in Combination With Immunotherapy and Targeted Therapy (NCT07065786) | Zhongda Hospital | 2024-01-01 |
| DEB-TACE With Visualable Microspheres Versus PVA Microspheres for HCC (NCT06190665) | Zhongda Hospital | 2023-12-19 |
| Robotic-assisted Percutaneous Transhepatic Puncture (NCT06195917) | Zhongda Hospital | 2023-09-19 |
| Safety and Efficacy of Polyvinyl Alcohol Sodium Acrylate Embolization Microspheres for CRLM (NCT06021015) | Zhongda Hospital | 2023-09-10 |
| Efficacy, Safety, and Treatment Patterns of Transcatheter Arterial Chemoembolization (TACE) Combined With Atezolizumab and Bevacizumab in Unresectable Hepatocellular Carcinoma: a Multicenter, Retrospective, Observational Real-world Study (NCT06024252) | Zhongda Hospital | 2023-09-01 |
| DDX17 Orchestrate Septic Vascular Endothelial Pyroptosis by Controlling Gasdermin D Pore Formation (NCT06013033) | Zhongda Hospital | 2023-09-01 |
| Clinical Study of TCR-like CAR-T Cell Targeted MSLN in the Treatment of Ovarian Cancer (NCT05963100) | Zhongda Hospital | 2023-08-07 |
| Radial Access for Abdominopelvic Vascular Intervention (NCT05956860) | Zhongda Hospital | 2023-08-07 |
| CXCL2/CXCL8 Promote Intervertebral Disc Degeneration (NCT05976516) | Zhongda Hospital | 2023-08-01 |
| High-Dose Atorvastatin for Vascular Wall Protection in Thrombectomy Patients (NCT05912686) | Zhongda Hospital | 2023-07-01 |
| Yttrium-90 Carbon Microspheres in Patients With Unresectable Hepatocellular Carcinoma (NCT05957640) | Zhongda Hospital | 2023-05-05 |
| Impact of Clinical Evident Portal Hypertension on HCC With TACE (CHANCE-CHESS 2301) (NCT05703750) | Zhongda Hospital | 2023-05-04 |
| CT-based HVPG Assessment for Predicting the Prognosis of HCC With TACE (CHANCE-CHESS 2302) (NCT05704192) | Zhongda Hospital | 2023-05-04 |
| A Real World Study of Regogfinib in HCC (NCT05557656) | Zhongda Hospital | 2023-01-05 |
| TACE in Combination With PD-1/PD-L1 Inhibitors and Molecular Target Therapies for Advanced HCC (NCT05332821) | Zhongda Hospital | 2022-12-28 |
| TACE in Combination With PD-1/PD-L1 Inhibitors and Molecular Target Therapies for Intermediate HCC (NCT05332496) | Zhongda Hospital | 2022-12-28 |
| Lipiodol-TACE With Idarubicin Based On a Specific Emulsion Ratio for Hepatocellular Carcinoma (NCT05631613) | Zhongda Hospital | 2022-12-28 |
| Yttrium-90 Carbon Microspheres in Patients With Unresectable Colorectal Liver Metastases (NCT05692037) | Zhongda Hospital | 2022-12-28 |
| Endovascular Denervation (EDN) for the Treatment of Type 2 Diabetes Mellitus (NCT05673668) | Zhongda Hospital | 2022-12-27 |
| TACE Combined With Penpulimab and Anlotinib for Advanced HCC (NCT05344924) | Zhongda Hospital | 2022-10-12 |
| Envafolimab, Lenvatinib Combined With VP-16 in Platinum-resistant Recurrent Epithelial Ovarian Cancer (NCT05422183) | Zhongda Hospital | 2022-06-30 |
| HAIC Combined With Donafenib and Sintilimab for Unresectable ICC (NCT05348811) | Zhongda Hospital | 2022-06-13 |
| Lipiodol-TACE With Idarubicin for Hepatocellular Carcinoma (NCT05280444) | Zhongda Hospital | 2022-05-28 |
| Endovascular Denervation for the Treatment of Patients With Peripheral Arterial Disease (NCT05345431) | Zhongda Hospital | 2022-04-25 |
| Assessing the Prognosis of TACE in Combination With PD-1/PD-L1 Inhibitors and Molecular Target Therapies for HCC by Using Clinical and Imaging Biomarkers (NCT05278195) | Zhongda Hospital | 2022-04-01 |
| Nalbuphine Versus Morphine for Perioperative Tumor Ablation (NCT05073744) | Zhongda Hospital | 2021-09-05 |
| Efficacy and Safety of TACE in Combination With ICIs for HCC: a Real-world Study (NCT04975932) | Zhongda Hospital | 2021-07-01 |
| REMS Combined With TAI for Unresectable HC (NCT04801160) | Zhongda Hospital | 2021-03-01 |
| Effects of Bashan on Glucose in Type 2 Diabetes Patients and Its Related Mechanisms (NCT05333822) | Zhongda Hospital | 2021-03-01 |
| Atezolizumab Plus Bevacizumab Combined With Locoregional Therapies in Unresectable Hepatocellular Carcinoma (ISMIO-001) (NCT07204327) | Zhongda Hospital | 2020-10-28 |
| Tislelizumab in Combination With TACE in Advanced Hepatocellular Carcinoma (NCT04652492) | Zhongda Hospital | 2020-10-27 |
| TACE Combined With Camrelizumab and Apatinib in Intermediate and Advanced Hepatocelluar Carcinoma (NCT04559607) | Zhongda Hospital | 2020-09-11 |
| Study of Efficacy and Safety of Flumatinib Combined With Chemotherapy in Ph Positive ALL (NCT04375683) | Zhongda Hospital | 2020-03-01 |
| Using Calcium Dobesilate to Treat Chinese Patients With Mild to Moderate Non-proliferative Diabetic Retinopathy (NCT04283162) | Zhongda Hospital | 2020-03-01 |
| The MILESTONE Study (NCT04086043) | Zhongda Hospital | 2019-09-10 |
| Endovascular Denervation Improves Limb Ischemia in Patients With Peripheral Artery Disease (NCT04060797) | Zhongda Hospital | 2019-08-23 |
| Effectiveness and Safety of Niraparib as First-line Maintenance Therapy for Ovarian Cancer: a Real-world Study (NCT05734911) | Zhongda Hospital | 2019-01-01 |
| Hospital Ederly Life Program for Surgical Patients (NCT03792373) | Zhongda Hospital | 2018-12-01 |
| Irradiation Stent Placement Plus TACE for HCC and PVTT (NCT03730675) | Zhongda Hospital | 2018-11-10 |
| Immune Checkpoint Inhibitors and Anti-vascular Endothelial Growth Factor Antibody/Tyrosine Kinase Inhibitors With or Without TACE for Advanced HCC With Vascular Invasions (NCT06881446) | Zhongda Hospital | 2018-06-01 |
| Regional Lymph Node Metastasis and Survival Outcomes in Advanced HCC (NCT06876753) | Zhongda Hospital | 2018-06-01 |
| Immune Checkpoint Inhibitors and Anti-vascular Endothelial Growth Factor Antibody/Tyrosine Kinase Inhibitors With or Without HAIC for Unresectable HCC With Portal Vein Tumor Thrombosis (NCT06881433) | Zhongda Hospital | 2018-06-01 |
| Identification of Risk Factors and Construction of Prediction Model for Postoperative Intestinal Anastomotic Leakage in Ovarian Cancer (NCT06458361) | Zhongda Hospital | 2018-01-01 |
| Dexmedetomidine for Prevention of Chronic Postoperative Pain (NCT03275207) | Zhongda Hospital | 2018-01-01 |
| Clinical Application of Novel Panels for Early Precision Diagnosis and Relapse Prediction in High-risk Leukemia (NCT03297476) | Zhongda Hospital | 2017-12-01 |
| Endovascular Denervation in Patients With Cancer Pain (NCT03431922) | Zhongda Hospital | 2017-09-21 |
| Effectiveness of Self-myofascial Release Combined With Biofeedback and Electrical Stimulation for the Management of MFPP (NCT04746352) | Zhongda Hospital | 2017-09-01 |
| Cooperative Group for Clinical Research in G-POEM (POP), Jiangsu, China (NCT03040817) | Zhongda Hospital | 2017-09-01 |